Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-15

Clinical Trial Update: Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing Dara-VCD chemotherapy with autologous stem cell transplant versus Dara-VCD chemotherapy alone in newly diagnosed AL amyloidosis; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bortezomib (bortezomib)
  • CYCLOPHOSPHAMIDE (Cyclophosphamide)
  • DEXAMETHASONE (Dexamethasone)
  • Daratumumab (daratumumab)

Snippet

Sponsor: SWOG Cancer Research Network | Conditions: AL Amyloidosis | Phase 3 | Status: RECRUITING